Strong Earnings, FDA Approval, and Takeover Interest Drive Lantheus Holdings’ (LNTH) Rally - Yahoo Finance
Why now
Thesis: Multiple catalysts converge on one name
Catalyst to watch: Formal takeover bid or approval details
Main risk: Takeover interest may not materialize
Why it matters
Earnings strength, FDA approval and takeover interest can drive a small-cap healthcare name sharply higher.
Related assets & topics
HealthcareSources
- googlenews · news.google.com · 2026-09-23 14:14 UTC